생명과학회지 (Journal of Life Science)

  • 제23권6호
  • /
  • Pages.832-837
  • /
  • 2013
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

글루타민 결핍에 의한 PC3 인체 전립선 암세포의 G2/M 세포주기 억제 유발

Induction of G2/M Cell Cycle Arrest by Glutamine Deprivation in Human Prostate Carcinoma PC3 Cells

  • 신동역 (동남권원자력의과학원) ;
  • 최성현 (한국승강기대학교 승강기시스템관리과) ;
  • 박동일 (동의대학교 한의과대학 내과학교실) ;
  • 최영현 (동의대학교 한의과대학 생화학교실)
  • Shin, Dong Yeok (Dongnam Institute of Radiological & Medicine Sciences) ;
  • Choi, Sung Hyun (Department of System Management, Korea Lift College) ;
  • Park, Dong Il (Department of Internal Medicine, Dongeui University College of Oriental Medicine) ;
  • Choi, Yung Hyun (Department of Biochemistry, Dongeui University College of Oriental Medicine)
  • 투고 : 2013.04.28
  • 심사 : 2013.06.26
  • 발행 : 2013.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

본 연구에서는 생체 내 구성요소 및 에너지원으로서 중요한 역할을 하는 글루타민 결핍에 의한 인체 전립선 PC3 암세포의 증식에 관한 기전 연구를 실시하였다. 글루타민 결핍에 의한 PC3 세포의 증식억제는 세포주기 G2/M arrest와 연관성이 있었으나, apoptosis 유발 현상은 관찰되지 않았다. 글루타민 결핍에 의한 G2/M arrest는 전사 및 번역 수준에서 Cdc2, cyclin A 및 cyclin B1의 발현 억제 및 p53 비의존적인 p21(WAF1/CIP1)의 발현 증가와 연관성이 있었다. 아울러 글루타민 결핍은 Chk1 및 Chk2의 인산화를 증가시켰으나, Cdc25C의 인산화는 감소시켰다. 본 연구의 결과는 글루타민 결핍에 의한 PC3 세포의 증식억제가 apoptosis 유발과는 상관없이 G2/M arrest를 유발시킨다는 첫 번째 증거이다.

In this study, it was investigated the possible mechanisms by which glutamine deprivation exerts its anti-proliferative action in cultured human prostate carcinoma PC3 cells. Glutamine deprivation resulted in inhibition of growth and G2/M arrest of the cell cycle in a time-dependent manner without apoptosis induction, as determined by MTT assay, DAPI staining and flow cytometry analyses. The induction of G2/M arrest by glutamine deprivation was associated with the inhibition of expression of Cdc2, cyclin A and cyclin B1, and up-regulation of the expression of cyclin-dependent kinase (Cdk) inhibitor p21(WAF1/CIP1) in both transcriptional and translational levels. Moreover, glutamine deprivation increased the phosphorylation of checkpoint kinase (Chk)1 and Chk2; however, the levels of Cdc25C phosphorylation were decreased in response to glutamine deprivation in a time-dependent manner. Our data provide a first biochemical evidence that glutamine deprivation suppresses cell viability through G2/M phase arrest without induction of apoptosis in PC3 cells.

키워드

참고문헌

  1. Boutros, R., Dozier, C. and Ducommun, B. 2006. The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 18, 185-191. https://doi.org/10.1016/j.ceb.2006.02.003
  2. Brasse-Lagnel, C., Lavoinne, A. and Husson, A. 2009. Control of mammalinan gene expression by amino acids, especially glutamine. FEBS J 276, 1826-1844. https://doi.org/10.1111/j.1742-4658.2009.06920.x
  3. Chow, A. and Zhang, R. 1998. Glutamine reduces heat shock-induced cell death in rat intestinal epithelial cells. J Nutr 128, 1296-1301.
  4. Cuddihy, A, 2003. O'Connell M. Cell-cycle responses to DNA damage in G2. Int Rev Cytol 222, 99-140. https://doi.org/10.1016/S0074-7696(02)22013-6
  5. Curthoys, N. P. and Watford, M. 1995. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 15, 133-159. https://doi.org/10.1146/annurev.nu.15.070195.001025
  6. DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. and Thompson, C. B. 2008. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7, 11-20. https://doi.org/10.1016/j.cmet.2007.10.002
  7. Drogat, B., Bouchecareilh, M., North, S., Petibois, C., Deleris, G., Chevet, E., Bikfalvi, A. and Moenner, M. 2007. Acute L-glutamine deprivation compromises VEGF-a upregulation in A549/8 human carcinoma cells. J Cell Physiol 212, 463-472. https://doi.org/10.1002/jcp.21044
  8. Eaton, C. L., Davies, P. and Phillips, M. E. 1998. Growth factor involvement and oncogene expression in prostatic tumours. J Steroid Biochem 30, 341-345.
  9. Exner, R., Weingartmann, G., Eliasen, M. M., Gerner, C., Spittler, A., Roth, E. and Oehler, R. 2002. Glutamine deficiency renders human monocytic cells more susceptible to specific apoptosis triggers. Surgery 131, 75-80. https://doi.org/10.1067/msy.2002.118318
  10. Fu, Y. M., Yu, Z. X., Li, Y. Q., Ge, X., Sanchez, P. J., Fu, X. and Meadows, G. G. 2003. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells. Nutr Cancer 45, 60-73. https://doi.org/10.1207/S15327914NC4501_8
  11. Fu, Y. M., Yu, Z. X., Lin, H., Fu, X. and Meadows, G. G. 2008. Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells. J Cell Physiol 217, 184-193. https://doi.org/10.1002/jcp.21490
  12. Fu, Y. M., Yu, Z. X., Pelayo, B. A., Ferrans, V. J. and Meadows, G. G. 1999. Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency. Cancer Res 59, 758-765.
  13. Fuchs, B. C. and Bode, B. P. 2006. Stressing out over survival: glutamine as an apoptotic modulator. J Surg Res 131, 26-40. https://doi.org/10.1016/j.jss.2005.07.013
  14. Fumarola, C., Zerbini, A. and Guidotti, G. G. 2001. Glutamine deprivation-mediated cell shrinkage induces ligand- independent CD95 receptor signaling and apoptosis. Cell Death Differ 8, 1004-1013. https://doi.org/10.1038/sj.cdd.4400902
  15. Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L. and Chiaradonna, F. 2009. Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts. PLoS One 4, e4715. https://doi.org/10.1371/journal.pone.0004715
  16. Gould, K. L. and Nurse, P. 1989. Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature 342, 39-45. https://doi.org/10.1038/342039a0
  17. Han, S. J. and Conti, M. 2006. New pathways from PKA to the Cdc2/cyclin B complex in oocytes: Wee1B as a potential PKA substrate. Cell Cycle 5, 227-231. https://doi.org/10.4161/cc.5.3.2395
  18. Haussinger, D. 1998. Hepatic glutamine transport and metabolism. Adv Enzymol Relat Areas Mol Biol 72, 43-86.
  19. Isaacs, W. B., Carter, B. S. and Ewing, C. M. 1991. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 51, 4716-4720.
  20. Ko, Y. G., Kim, E. K., Kim, T., Park, H., Park, H. S., Choi, E. J. and Kim, S. 2001. Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1. J Biol Chem 276, 6030-6036. https://doi.org/10.1074/jbc.M006189200
  21. Koochekpour, S., Majumdar, S., Azabdaftari, G., Attwood, K., Scioneaux, R., Subramani, D., Manhardt, C., Lorusso, G. D., Willard, S. S., Thompson, H., Shourideh, M., Rezaei, K., Sartor, O., Mohler, J. L. and Vessella, R. L. 2012. Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res 18, 5888-5901. https://doi.org/10.1158/1078-0432.CCR-12-1308
  22. Lee, W. J., Hawkins, R. A., Wina, J. R. and Peterson, D. R. 1998. Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal. Am J Physiol Cell Physiol 274, C1101-C1107.
  23. Mates, J. M., Segura, J. A., Alonso, F. J. and Marquez, J. 2006. Pathways from glutamine to apoptosis. Front Biosci 11, 3164-3180. https://doi.org/10.2741/2040
  24. Morgan, M. A., Parsels, L. A., Parsels, J. D., Mesiwala, A. K., Maybaum, J. and Lawrence, T. S. 2005. Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine. Cancer Res 65, 6835-6842. https://doi.org/10.1158/0008-5472.CAN-04-2246
  25. Niida, H. 2006. Nakanishi M. DNA damage checkpoints in mammals. Mutagenesis 21, 3-9.
  26. Petronini, P. G., Urbani, S., Alfieri, R., Borghetti, A. F. and Guidotti, G. G. 1996. Cell susceptibility to apoptosis by glutamine deprivation and rescue: survival and apoptotic death in cultured lymphoma-leukemia cell lines. J Cell Physiol 169, 175-185. https://doi.org/10.1002/(SICI)1097-4652(199610)169:1<175::AID-JCP18>3.0.CO;2-C
  27. Qing, G., Li, B., Vu, A., Skuli, N., Walton, Z. E., Liu, X., Mayes, P. A., Wise, D. R., Thompson, C. B., Maris, J. M., Hogarty, M. D. and Simon, M. C. 2012. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell 22, 631-644. https://doi.org/10.1016/j.ccr.2012.09.021
  28. Raleigh, J. M. and O’Connell, M. J. 2000. The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J Cell Sci 113, 1727-1736.
  29. Rosenthal, D. I. and Trotti, A. 2009. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 19, 29-34. https://doi.org/10.1016/j.semradonc.2008.09.006
  30. Weinberg, F. and Chandel, N. S. 2009. Mitochondrial metabolism and cancer. Ann NY Acad Sci 1177, 66-73. https://doi.org/10.1111/j.1749-6632.2009.05039.x
  31. Wischmeyer, P. E., Musch, M. W., Madonna, M. B., Thisted, R. and Chang, E. B. 1997. Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol 272, G879-G884.
  32. Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R. and Lazebnik, Y. 2007. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 178, 93-105. https://doi.org/10.1083/jcb.200703099